nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—PTGS1—Dapsone—systemic lupus erythematosus	0.0824	0.109	CbGbCtD
Ketamine—CYP2C8—Dapsone—systemic lupus erythematosus	0.0475	0.0631	CbGbCtD
Ketamine—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0465	0.0618	CbGbCtD
Ketamine—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0412	0.0547	CbGbCtD
Ketamine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0368	0.0489	CbGbCtD
Ketamine—CYP2C9—Dapsone—systemic lupus erythematosus	0.0331	0.044	CbGbCtD
Ketamine—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0331	0.0439	CbGbCtD
Ketamine—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0312	0.0415	CbGbCtD
Ketamine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0279	0.037	CbGbCtD
Ketamine—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.0272	0.0361	CbGbCtD
Ketamine—ABCB1—Betamethasone—systemic lupus erythematosus	0.0239	0.0318	CbGbCtD
Ketamine—ABCB1—Prednisolone—systemic lupus erythematosus	0.0236	0.0314	CbGbCtD
Ketamine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0224	0.0297	CbGbCtD
Ketamine—ABCB1—Prednisone—systemic lupus erythematosus	0.0223	0.0296	CbGbCtD
Ketamine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0221	0.0293	CbGbCtD
Ketamine—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0218	0.0289	CbGbCtD
Ketamine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0211	0.0281	CbGbCtD
Ketamine—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0206	0.0273	CbGbCtD
Ketamine—CYP3A4—Dapsone—systemic lupus erythematosus	0.0193	0.0256	CbGbCtD
Ketamine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0167	0.0222	CbGbCtD
Ketamine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0167	0.0222	CbGbCtD
Ketamine—CYP2C9—cardial valve—systemic lupus erythematosus	0.0154	0.152	CbGeAlD
Ketamine—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0143	0.019	CbGbCtD
Ketamine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0143	0.019	CbGbCtD
Ketamine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0141	0.0188	CbGbCtD
Ketamine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0139	0.0185	CbGbCtD
Ketamine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0134	0.0178	CbGbCtD
Ketamine—CYP3A4—Prednisone—systemic lupus erythematosus	0.0134	0.0177	CbGbCtD
Ketamine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0127	0.0168	CbGbCtD
Ketamine—ABCB1—Methotrexate—systemic lupus erythematosus	0.0112	0.0149	CbGbCtD
Ketamine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00834	0.0111	CbGbCtD
Ketamine—GRIN3B—lung—systemic lupus erythematosus	0.00516	0.0509	CbGeAlD
Ketamine—CYP2C9—urine—systemic lupus erythematosus	0.00332	0.0328	CbGeAlD
Ketamine—Obstructive airways disorder—Methotrexate—systemic lupus erythematosus	0.00317	0.0363	CcSEcCtD
Ketamine—TACR1—connective tissue—systemic lupus erythematosus	0.00312	0.0307	CbGeAlD
Ketamine—Epilepsy—Hydrocortisone—systemic lupus erythematosus	0.00304	0.0349	CcSEcCtD
Ketamine—GRIN2D—tendon—systemic lupus erythematosus	0.00263	0.0259	CbGeAlD
Ketamine—Epilepsy—Betamethasone—systemic lupus erythematosus	0.0026	0.0298	CcSEcCtD
Ketamine—Epilepsy—Dexamethasone—systemic lupus erythematosus	0.0026	0.0298	CcSEcCtD
Ketamine—CYP3A4—urine—systemic lupus erythematosus	0.00253	0.025	CbGeAlD
Ketamine—GRIN2C—nervous system—systemic lupus erythematosus	0.0023	0.0227	CbGeAlD
Ketamine—Epilepsy—Prednisone—systemic lupus erythematosus	0.00226	0.026	CcSEcCtD
Ketamine—GRIN2C—central nervous system—systemic lupus erythematosus	0.00221	0.0218	CbGeAlD
Ketamine—OPRD1—kidney—systemic lupus erythematosus	0.00216	0.0213	CbGeAlD
Ketamine—GRIN2D—nervous system—systemic lupus erythematosus	0.00213	0.0211	CbGeAlD
Ketamine—GRIN2D—central nervous system—systemic lupus erythematosus	0.00206	0.0203	CbGeAlD
Ketamine—GRIN3A—nervous system—systemic lupus erythematosus	0.00201	0.0198	CbGeAlD
Ketamine—GRIN2A—tendon—systemic lupus erythematosus	0.00195	0.0193	CbGeAlD
Ketamine—CYP2C8—blood plasma—systemic lupus erythematosus	0.00195	0.0193	CbGeAlD
Ketamine—GRIN3A—central nervous system—systemic lupus erythematosus	0.00193	0.0191	CbGeAlD
Ketamine—GRIN1—nervous system—systemic lupus erythematosus	0.0019	0.0188	CbGeAlD
Ketamine—TACR1—lung—systemic lupus erythematosus	0.00188	0.0185	CbGeAlD
Ketamine—GRIN1—central nervous system—systemic lupus erythematosus	0.00183	0.0181	CbGeAlD
Ketamine—GRIN2B—nervous system—systemic lupus erythematosus	0.00182	0.0179	CbGeAlD
Ketamine—PTGS1—endothelium—systemic lupus erythematosus	0.00178	0.0176	CbGeAlD
Ketamine—Nystagmus—Mycophenolate mofetil—systemic lupus erythematosus	0.00178	0.0204	CcSEcCtD
Ketamine—CYP2B6—blood plasma—systemic lupus erythematosus	0.00175	0.0173	CbGeAlD
Ketamine—GRIN2B—central nervous system—systemic lupus erythematosus	0.00175	0.0172	CbGeAlD
Ketamine—TACR1—nervous system—systemic lupus erythematosus	0.00174	0.0172	CbGeAlD
Ketamine—CYP2C9—blood plasma—systemic lupus erythematosus	0.00173	0.0171	CbGeAlD
Ketamine—Laryngospasm—Mycophenolate mofetil—systemic lupus erythematosus	0.0017	0.0195	CcSEcCtD
Ketamine—TACR1—central nervous system—systemic lupus erythematosus	0.00168	0.0165	CbGeAlD
Ketamine—Cystitis noninfective—Leflunomide—systemic lupus erythematosus	0.00165	0.0189	CcSEcCtD
Ketamine—Cystitis—Leflunomide—systemic lupus erythematosus	0.00163	0.0187	CcSEcCtD
Ketamine—GRIN2A—nervous system—systemic lupus erythematosus	0.00159	0.0157	CbGeAlD
Ketamine—PTGS1—blood plasma—systemic lupus erythematosus	0.00158	0.0156	CbGeAlD
Ketamine—GRIN2A—central nervous system—systemic lupus erythematosus	0.00153	0.0151	CbGeAlD
Ketamine—Bladder pain—Leflunomide—systemic lupus erythematosus	0.00152	0.0175	CcSEcCtD
Ketamine—Apnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.0015	0.0172	CcSEcCtD
Ketamine—OPRD1—nervous system—systemic lupus erythematosus	0.00141	0.014	CbGeAlD
Ketamine—Erythema—Dapsone—systemic lupus erythematosus	0.00138	0.0158	CcSEcCtD
Ketamine—OPRD1—central nervous system—systemic lupus erythematosus	0.00136	0.0134	CbGeAlD
Ketamine—OPRK1—nervous system—systemic lupus erythematosus	0.00136	0.0134	CbGeAlD
Ketamine—CYP3A4—blood plasma—systemic lupus erythematosus	0.00132	0.013	CbGeAlD
Ketamine—OPRK1—central nervous system—systemic lupus erythematosus	0.00131	0.0129	CbGeAlD
Ketamine—Vision blurred—Dapsone—systemic lupus erythematosus	0.0013	0.0149	CcSEcCtD
Ketamine—Cystitis noninfective—Mycophenolate mofetil—systemic lupus erythematosus	0.00124	0.0142	CcSEcCtD
Ketamine—Cystitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00123	0.0141	CcSEcCtD
Ketamine—Bladder pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00115	0.0132	CcSEcCtD
Ketamine—OPRM1—nervous system—systemic lupus erythematosus	0.000964	0.00952	CbGeAlD
Ketamine—ABCB1—blood plasma—systemic lupus erythematosus	0.000935	0.00923	CbGeAlD
Ketamine—OPRM1—central nervous system—systemic lupus erythematosus	0.000929	0.00916	CbGeAlD
Ketamine—Diplopia—Mycophenolate mofetil—systemic lupus erythematosus	0.000921	0.0106	CcSEcCtD
Ketamine—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000902	0.00891	CbGeAlD
Ketamine—CYP2C8—kidney—systemic lupus erythematosus	0.000884	0.00873	CbGeAlD
Ketamine—Apnoea—Methotrexate—systemic lupus erythematosus	0.000848	0.00973	CcSEcCtD
Ketamine—PTGS1—connective tissue—systemic lupus erythematosus	0.000842	0.00831	CbGeAlD
Ketamine—CYP2B6—skin of body—systemic lupus erythematosus	0.000841	0.0083	CbGeAlD
Ketamine—Arrhythmia—Azathioprine—systemic lupus erythematosus	0.000801	0.00918	CcSEcCtD
Ketamine—CYP2B6—kidney—systemic lupus erythematosus	0.000793	0.00783	CbGeAlD
Ketamine—SLC6A2—lung—systemic lupus erythematosus	0.000763	0.00753	CbGeAlD
Ketamine—PTGS1—skin of body—systemic lupus erythematosus	0.00076	0.00751	CbGeAlD
Ketamine—Arrhythmia—Leflunomide—systemic lupus erythematosus	0.000756	0.00867	CcSEcCtD
Ketamine—PTGS1—kidney—systemic lupus erythematosus	0.000717	0.00708	CbGeAlD
Ketamine—Vomiting—Dapsone—systemic lupus erythematosus	0.000716	0.00821	CcSEcCtD
Ketamine—SLC6A2—nervous system—systemic lupus erythematosus	0.000706	0.00697	CbGeAlD
Ketamine—Cystitis noninfective—Methotrexate—systemic lupus erythematosus	0.000702	0.00805	CcSEcCtD
Ketamine—DRD2—lung—systemic lupus erythematosus	0.000695	0.00686	CbGeAlD
Ketamine—Vision blurred—Leflunomide—systemic lupus erythematosus	0.000695	0.00797	CcSEcCtD
Ketamine—Cystitis—Methotrexate—systemic lupus erythematosus	0.000694	0.00796	CcSEcCtD
Ketamine—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000681	0.00672	CbGeAlD
Ketamine—SLC6A2—central nervous system—systemic lupus erythematosus	0.00068	0.00671	CbGeAlD
Ketamine—Nausea—Dapsone—systemic lupus erythematosus	0.000669	0.00767	CcSEcCtD
Ketamine—Bladder pain—Methotrexate—systemic lupus erythematosus	0.00065	0.00746	CcSEcCtD
Ketamine—Bradycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000649	0.00744	CcSEcCtD
Ketamine—DRD2—nervous system—systemic lupus erythematosus	0.000643	0.00635	CbGeAlD
Ketamine—DRD2—central nervous system—systemic lupus erythematosus	0.00062	0.00611	CbGeAlD
Ketamine—Bradycardia—Prednisolone—systemic lupus erythematosus	0.000605	0.00694	CcSEcCtD
Ketamine—Anaphylactic shock—Leflunomide—systemic lupus erythematosus	0.000601	0.0069	CcSEcCtD
Ketamine—CYP3A4—kidney—systemic lupus erythematosus	0.000599	0.00591	CbGeAlD
Ketamine—Hypotension—Azathioprine—systemic lupus erythematosus	0.000595	0.00683	CcSEcCtD
Ketamine—Bradycardia—Hydrocortisone—systemic lupus erythematosus	0.000591	0.00678	CcSEcCtD
Ketamine—Arrhythmia—Cyclosporine—systemic lupus erythematosus	0.000584	0.00669	CcSEcCtD
Ketamine—PTGS1—tendon—systemic lupus erythematosus	0.000579	0.00571	CbGeAlD
Ketamine—Anorexia—Leflunomide—systemic lupus erythematosus	0.000573	0.00658	CcSEcCtD
Ketamine—Arrhythmia—Mycophenolate mofetil—systemic lupus erythematosus	0.000569	0.00653	CcSEcCtD
Ketamine—Hypotension—Leflunomide—systemic lupus erythematosus	0.000562	0.00645	CcSEcCtD
Ketamine—CYP2B6—lung—systemic lupus erythematosus	0.000562	0.00555	CbGeAlD
Ketamine—Bradycardia—Triamcinolone—systemic lupus erythematosus	0.000557	0.00638	CcSEcCtD
Ketamine—Bradycardia—Methylprednisolone—systemic lupus erythematosus	0.000555	0.00637	CcSEcCtD
Ketamine—Vision blurred—Cyclosporine—systemic lupus erythematosus	0.000536	0.00615	CcSEcCtD
Ketamine—Arrhythmia—Prednisolone—systemic lupus erythematosus	0.000531	0.00609	CcSEcCtD
Ketamine—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000523	0.006	CcSEcCtD
Ketamine—CYP2B6—nervous system—systemic lupus erythematosus	0.00052	0.00514	CbGeAlD
Ketamine—Arrhythmia—Hydrocortisone—systemic lupus erythematosus	0.000519	0.00595	CcSEcCtD
Ketamine—Erythema—Prednisolone—systemic lupus erythematosus	0.000518	0.00594	CcSEcCtD
Ketamine—Pain—Leflunomide—systemic lupus erythematosus	0.000514	0.0059	CcSEcCtD
Ketamine—PTGS1—lung—systemic lupus erythematosus	0.000508	0.00501	CbGeAlD
Ketamine—Erythema—Hydrocortisone—systemic lupus erythematosus	0.000505	0.0058	CcSEcCtD
Ketamine—Bradycardia—Betamethasone—systemic lupus erythematosus	0.000505	0.00579	CcSEcCtD
Ketamine—Bradycardia—Dexamethasone—systemic lupus erythematosus	0.000505	0.00579	CcSEcCtD
Ketamine—CYP2B6—central nervous system—systemic lupus erythematosus	0.000501	0.00494	CbGeAlD
Ketamine—Convulsion—Cyclosporine—systemic lupus erythematosus	0.000493	0.00565	CcSEcCtD
Ketamine—Arrhythmia—Triamcinolone—systemic lupus erythematosus	0.000488	0.0056	CcSEcCtD
Ketamine—Vision blurred—Prednisolone—systemic lupus erythematosus	0.000488	0.00559	CcSEcCtD
Ketamine—Arrhythmia—Methylprednisolone—systemic lupus erythematosus	0.000487	0.00559	CcSEcCtD
Ketamine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000482	0.00476	CbGeAlD
Ketamine—Convulsion—Mycophenolate mofetil—systemic lupus erythematosus	0.000481	0.00551	CcSEcCtD
Ketamine—Erythema—Triamcinolone—systemic lupus erythematosus	0.000476	0.00546	CcSEcCtD
Ketamine—Erythema—Methylprednisolone—systemic lupus erythematosus	0.000475	0.00545	CcSEcCtD
Ketamine—PTGS1—nervous system—systemic lupus erythematosus	0.00047	0.00464	CbGeAlD
Ketamine—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000464	0.00532	CcSEcCtD
Ketamine—PTGS1—central nervous system—systemic lupus erythematosus	0.000453	0.00447	CbGeAlD
Ketamine—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000453	0.00519	CcSEcCtD
Ketamine—Convulsion—Prednisolone—systemic lupus erythematosus	0.000448	0.00514	CcSEcCtD
Ketamine—Shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000445	0.00511	CcSEcCtD
Ketamine—Arrhythmia—Dexamethasone—systemic lupus erythematosus	0.000443	0.00508	CcSEcCtD
Ketamine—Arrhythmia—Betamethasone—systemic lupus erythematosus	0.000443	0.00508	CcSEcCtD
Ketamine—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000442	0.00507	CcSEcCtD
Ketamine—Bradycardia—Prednisone—systemic lupus erythematosus	0.00044	0.00504	CcSEcCtD
Ketamine—Convulsion—Hydrocortisone—systemic lupus erythematosus	0.000438	0.00502	CcSEcCtD
Ketamine—Erythema—Betamethasone—systemic lupus erythematosus	0.000432	0.00495	CcSEcCtD
Ketamine—Erythema—Dexamethasone—systemic lupus erythematosus	0.000432	0.00495	CcSEcCtD
Ketamine—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000432	0.00495	CcSEcCtD
Ketamine—ABCB1—kidney—systemic lupus erythematosus	0.000424	0.00418	CbGeAlD
Ketamine—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000423	0.00485	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000422	0.00484	CcSEcCtD
Ketamine—Shock—Prednisolone—systemic lupus erythematosus	0.000416	0.00477	CcSEcCtD
Ketamine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000413	0.00407	CbGeAlD
Ketamine—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000413	0.00473	CcSEcCtD
Ketamine—Convulsion—Triamcinolone—systemic lupus erythematosus	0.000412	0.00473	CcSEcCtD
Ketamine—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.000411	0.00472	CcSEcCtD
Ketamine—Shock—Hydrocortisone—systemic lupus erythematosus	0.000406	0.00465	CcSEcCtD
Ketamine—Vomiting—Azathioprine—systemic lupus erythematosus	0.000405	0.00464	CcSEcCtD
Ketamine—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000404	0.00463	CcSEcCtD
Ketamine—Rash—Azathioprine—systemic lupus erythematosus	0.000402	0.00461	CcSEcCtD
Ketamine—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000401	0.0046	CcSEcCtD
Ketamine—Pain—Cyclosporine—systemic lupus erythematosus	0.000397	0.00455	CcSEcCtD
Ketamine—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000394	0.00451	CcSEcCtD
Ketamine—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000393	0.00451	CcSEcCtD
Ketamine—CYP3A4—nervous system—systemic lupus erythematosus	0.000393	0.00388	CbGeAlD
Ketamine—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000388	0.00446	CcSEcCtD
Ketamine—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000388	0.00445	CcSEcCtD
Ketamine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000387	0.00444	CcSEcCtD
Ketamine—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000386	0.00443	CcSEcCtD
Ketamine—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000385	0.00442	CcSEcCtD
Ketamine—Vomiting—Leflunomide—systemic lupus erythematosus	0.000382	0.00439	CcSEcCtD
Ketamine—Shock—Triamcinolone—systemic lupus erythematosus	0.000382	0.00438	CcSEcCtD
Ketamine—Shock—Methylprednisolone—systemic lupus erythematosus	0.000381	0.00437	CcSEcCtD
Ketamine—Rash—Leflunomide—systemic lupus erythematosus	0.000379	0.00435	CcSEcCtD
Ketamine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000379	0.00435	CcSEcCtD
Ketamine—Nausea—Azathioprine—systemic lupus erythematosus	0.000378	0.00434	CcSEcCtD
Ketamine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000378	0.00373	CbGeAlD
Ketamine—Erythema—Prednisone—systemic lupus erythematosus	0.000376	0.00431	CcSEcCtD
Ketamine—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000374	0.00429	CcSEcCtD
Ketamine—Convulsion—Betamethasone—systemic lupus erythematosus	0.000374	0.00429	CcSEcCtD
Ketamine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000364	0.00359	CbGeAlD
Ketamine—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000362	0.00415	CcSEcCtD
Ketamine—Pain—Prednisolone—systemic lupus erythematosus	0.000361	0.00414	CcSEcCtD
Ketamine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000359	0.00411	CcSEcCtD
Ketamine—Nausea—Leflunomide—systemic lupus erythematosus	0.000357	0.0041	CcSEcCtD
Ketamine—Vision blurred—Prednisone—systemic lupus erythematosus	0.000354	0.00407	CcSEcCtD
Ketamine—Pain—Hydrocortisone—systemic lupus erythematosus	0.000353	0.00405	CcSEcCtD
Ketamine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000352	0.00404	CcSEcCtD
Ketamine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000352	0.00404	CcSEcCtD
Ketamine—Shock—Dexamethasone—systemic lupus erythematosus	0.000347	0.00398	CcSEcCtD
Ketamine—Shock—Betamethasone—systemic lupus erythematosus	0.000347	0.00398	CcSEcCtD
Ketamine—Anorexia—Betamethasone—systemic lupus erythematosus	0.000336	0.00385	CcSEcCtD
Ketamine—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000336	0.00385	CcSEcCtD
Ketamine—Pain—Triamcinolone—systemic lupus erythematosus	0.000332	0.00381	CcSEcCtD
Ketamine—ABCB1—bone marrow—systemic lupus erythematosus	0.000332	0.00327	CbGeAlD
Ketamine—Hypotension—Betamethasone—systemic lupus erythematosus	0.000329	0.00378	CcSEcCtD
Ketamine—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000329	0.00378	CcSEcCtD
Ketamine—Convulsion—Prednisone—systemic lupus erythematosus	0.000326	0.00374	CcSEcCtD
Ketamine—Erythema—Methotrexate—systemic lupus erythematosus	0.000314	0.0036	CcSEcCtD
Ketamine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000307	0.00352	CcSEcCtD
Ketamine—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000306	0.00351	CcSEcCtD
Ketamine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000306	0.00351	CcSEcCtD
Ketamine—Shock—Prednisone—systemic lupus erythematosus	0.000302	0.00346	CcSEcCtD
Ketamine—Pain—Dexamethasone—systemic lupus erythematosus	0.000301	0.00346	CcSEcCtD
Ketamine—Pain—Betamethasone—systemic lupus erythematosus	0.000301	0.00346	CcSEcCtD
Ketamine—ABCB1—lung—systemic lupus erythematosus	0.0003	0.00296	CbGeAlD
Ketamine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000296	0.0034	CcSEcCtD
Ketamine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000295	0.00338	CcSEcCtD
Ketamine—Rash—Cyclosporine—systemic lupus erythematosus	0.000293	0.00336	CcSEcCtD
Ketamine—Anorexia—Prednisone—systemic lupus erythematosus	0.000293	0.00336	CcSEcCtD
Ketamine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000292	0.00335	CcSEcCtD
Ketamine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000288	0.0033	CcSEcCtD
Ketamine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000286	0.00327	CcSEcCtD
Ketamine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000285	0.00327	CcSEcCtD
Ketamine—ABCB1—nervous system—systemic lupus erythematosus	0.000278	0.00274	CbGeAlD
Ketamine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000276	0.00316	CcSEcCtD
Ketamine—Convulsion—Methotrexate—systemic lupus erythematosus	0.000272	0.00312	CcSEcCtD
Ketamine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000269	0.00308	CcSEcCtD
Ketamine—ABCB1—central nervous system—systemic lupus erythematosus	0.000268	0.00264	CbGeAlD
Ketamine—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000267	0.00306	CcSEcCtD
Ketamine—Rash—Prednisolone—systemic lupus erythematosus	0.000266	0.00305	CcSEcCtD
Ketamine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000266	0.00305	CcSEcCtD
Ketamine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000262	0.00301	CcSEcCtD
Ketamine—Rash—Hydrocortisone—systemic lupus erythematosus	0.00026	0.00298	CcSEcCtD
Ketamine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.00026	0.00298	CcSEcCtD
Ketamine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000257	0.00294	CcSEcCtD
Ketamine—Nausea—Prednisolone—systemic lupus erythematosus	0.000251	0.00288	CcSEcCtD
Ketamine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000247	0.00283	CcSEcCtD
Ketamine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000246	0.00283	CcSEcCtD
Ketamine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000245	0.00281	CcSEcCtD
Ketamine—Rash—Triamcinolone—systemic lupus erythematosus	0.000245	0.00281	CcSEcCtD
Ketamine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000245	0.00281	CcSEcCtD
Ketamine—Anorexia—Methotrexate—systemic lupus erythematosus	0.000245	0.0028	CcSEcCtD
Ketamine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000244	0.0028	CcSEcCtD
Ketamine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000244	0.0028	CcSEcCtD
Ketamine—Hypotension—Methotrexate—systemic lupus erythematosus	0.00024	0.00275	CcSEcCtD
Ketamine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000231	0.00265	CcSEcCtD
Ketamine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00023	0.00264	CcSEcCtD
Ketamine—Vomiting—Betamethasone—systemic lupus erythematosus	0.000224	0.00257	CcSEcCtD
Ketamine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000224	0.00257	CcSEcCtD
Ketamine—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000223	0.00256	CcSEcCtD
Ketamine—Rash—Dexamethasone—systemic lupus erythematosus	0.000222	0.00255	CcSEcCtD
Ketamine—Rash—Betamethasone—systemic lupus erythematosus	0.000222	0.00255	CcSEcCtD
Ketamine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000222	0.00255	CcSEcCtD
Ketamine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000222	0.00255	CcSEcCtD
Ketamine—Pain—Methotrexate—systemic lupus erythematosus	0.000219	0.00252	CcSEcCtD
Ketamine—Nausea—Dexamethasone—systemic lupus erythematosus	0.000209	0.0024	CcSEcCtD
Ketamine—Nausea—Betamethasone—systemic lupus erythematosus	0.000209	0.0024	CcSEcCtD
Ketamine—Vomiting—Prednisone—systemic lupus erythematosus	0.000195	0.00224	CcSEcCtD
Ketamine—Rash—Prednisone—systemic lupus erythematosus	0.000194	0.00222	CcSEcCtD
Ketamine—Dermatitis—Prednisone—systemic lupus erythematosus	0.000193	0.00222	CcSEcCtD
Ketamine—Nausea—Prednisone—systemic lupus erythematosus	0.000182	0.00209	CcSEcCtD
Ketamine—Vomiting—Methotrexate—systemic lupus erythematosus	0.000163	0.00187	CcSEcCtD
Ketamine—Rash—Methotrexate—systemic lupus erythematosus	0.000162	0.00186	CcSEcCtD
Ketamine—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000162	0.00185	CcSEcCtD
Ketamine—Nausea—Methotrexate—systemic lupus erythematosus	0.000152	0.00175	CcSEcCtD
Ketamine—GRIN2B—Axon guidance—IL6—systemic lupus erythematosus	2.87e-05	0.000492	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	2.87e-05	0.000491	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.84e-05	0.000487	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.8e-05	0.00048	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TLR9—systemic lupus erythematosus	2.79e-05	0.000478	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TGFB1—systemic lupus erythematosus	2.79e-05	0.000478	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—C3—systemic lupus erythematosus	2.78e-05	0.000476	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	2.78e-05	0.000476	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	2.75e-05	0.000471	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TGFB1—systemic lupus erythematosus	2.72e-05	0.000466	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	2.71e-05	0.000464	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.7e-05	0.000463	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NCF2—systemic lupus erythematosus	2.69e-05	0.000461	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—F2—systemic lupus erythematosus	2.69e-05	0.00046	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—C3—systemic lupus erythematosus	2.68e-05	0.00046	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—LYN—systemic lupus erythematosus	2.67e-05	0.000458	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—F2—systemic lupus erythematosus	2.67e-05	0.000458	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.63e-05	0.000451	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.62e-05	0.000449	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TNF—systemic lupus erythematosus	2.6e-05	0.000446	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	2.57e-05	0.00044	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—F2—systemic lupus erythematosus	2.56e-05	0.000439	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.55e-05	0.000437	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TNF—systemic lupus erythematosus	2.54e-05	0.000435	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.49e-05	0.000427	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CSK—systemic lupus erythematosus	2.48e-05	0.000426	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.46e-05	0.000421	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CD80—systemic lupus erythematosus	2.45e-05	0.00042	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.45e-05	0.00042	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.45e-05	0.00042	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—F2—systemic lupus erythematosus	2.44e-05	0.000418	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—C3—systemic lupus erythematosus	2.44e-05	0.000418	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.41e-05	0.000414	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.41e-05	0.000412	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	2.39e-05	0.00041	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CCL2—systemic lupus erythematosus	2.38e-05	0.000408	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—F2—systemic lupus erythematosus	2.36e-05	0.000404	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.34e-05	0.000401	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	2.33e-05	0.000399	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	2.32e-05	0.000398	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	2.29e-05	0.000392	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.29e-05	0.000392	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.28e-05	0.000391	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NCF2—systemic lupus erythematosus	2.27e-05	0.000389	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—C3—systemic lupus erythematosus	2.27e-05	0.000389	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.26e-05	0.000387	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—LYN—systemic lupus erythematosus	2.26e-05	0.000387	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.22e-05	0.000381	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.22e-05	0.00038	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PRL—systemic lupus erythematosus	2.22e-05	0.00038	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.21e-05	0.000379	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.21e-05	0.000378	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.17e-05	0.000373	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	2.17e-05	0.000372	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.15e-05	0.000368	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—F2—systemic lupus erythematosus	2.14e-05	0.000367	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NAT2—systemic lupus erythematosus	2.12e-05	0.000363	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TLR9—systemic lupus erythematosus	2.11e-05	0.000362	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.11e-05	0.000362	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.11e-05	0.000361	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—IL6—systemic lupus erythematosus	2.1e-05	0.00036	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.08e-05	0.000356	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.07e-05	0.000355	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—C3—systemic lupus erythematosus	2.06e-05	0.000353	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—IL6—systemic lupus erythematosus	2.05e-05	0.000351	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.05e-05	0.000351	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.05e-05	0.000351	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.03e-05	0.000348	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2e-05	0.000344	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—F2—systemic lupus erythematosus	1.99e-05	0.000341	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.99e-05	0.00034	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—IL6—systemic lupus erythematosus	1.98e-05	0.000339	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.97e-05	0.000338	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.95e-05	0.000334	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PRL—systemic lupus erythematosus	1.94e-05	0.000333	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.93e-05	0.000331	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.91e-05	0.000327	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CSK—systemic lupus erythematosus	1.88e-05	0.000323	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.87e-05	0.000321	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.86e-05	0.000318	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.84e-05	0.000316	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.84e-05	0.000315	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.82e-05	0.000311	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.81e-05	0.00031	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—F2—systemic lupus erythematosus	1.81e-05	0.00031	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	1.79e-05	0.000308	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JUNB—systemic lupus erythematosus	1.78e-05	0.000306	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.77e-05	0.000304	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.76e-05	0.000302	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.76e-05	0.000301	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.74e-05	0.000298	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.73e-05	0.000297	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.73e-05	0.000297	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL2—systemic lupus erythematosus	1.72e-05	0.000295	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NCF2—systemic lupus erythematosus	1.72e-05	0.000295	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—C3—systemic lupus erythematosus	1.72e-05	0.000295	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.71e-05	0.000294	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LYN—systemic lupus erythematosus	1.71e-05	0.000293	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.69e-05	0.00029	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.69e-05	0.00029	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.69e-05	0.000289	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.68e-05	0.000288	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.68e-05	0.000288	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.66e-05	0.000284	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.64e-05	0.000282	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PRL—systemic lupus erythematosus	1.64e-05	0.000282	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—C3—systemic lupus erythematosus	1.64e-05	0.000281	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.63e-05	0.00028	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.63e-05	0.000279	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.61e-05	0.000276	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.6e-05	0.000274	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.59e-05	0.000272	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.58e-05	0.000271	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.57e-05	0.00027	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.56e-05	0.000268	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—C3—systemic lupus erythematosus	1.56e-05	0.000267	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	1.56e-05	0.000267	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.55e-05	0.000266	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.55e-05	0.000265	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—F2—systemic lupus erythematosus	1.51e-05	0.000259	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.47e-05	0.000252	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.46e-05	0.000251	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.46e-05	0.000251	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.46e-05	0.00025	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.45e-05	0.000249	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.44e-05	0.000248	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—F2—systemic lupus erythematosus	1.44e-05	0.000247	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.44e-05	0.000247	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—C3—systemic lupus erythematosus	1.44e-05	0.000247	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.43e-05	0.000244	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CD80—systemic lupus erythematosus	1.38e-05	0.000237	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.38e-05	0.000236	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—F2—systemic lupus erythematosus	1.37e-05	0.000235	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUNB—systemic lupus erythematosus	1.35e-05	0.000232	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.34e-05	0.00023	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.34e-05	0.00023	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.31e-05	0.000225	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.28e-05	0.00022	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.28e-05	0.00022	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.28e-05	0.00022	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—F2—systemic lupus erythematosus	1.26e-05	0.000217	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.24e-05	0.000213	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRL—systemic lupus erythematosus	1.24e-05	0.000213	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.23e-05	0.00021	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.22e-05	0.000209	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.22e-05	0.000209	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—C3—systemic lupus erythematosus	1.22e-05	0.000209	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CD80—systemic lupus erythematosus	1.21e-05	0.000208	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—RXRA—systemic lupus erythematosus	1.19e-05	0.000204	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.17e-05	0.0002	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.16e-05	0.000199	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.14e-05	0.000196	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.13e-05	0.000193	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.12e-05	0.000192	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.11e-05	0.00019	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—F2—systemic lupus erythematosus	1.07e-05	0.000183	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.06e-05	0.000182	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.04e-05	0.000179	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CD80—systemic lupus erythematosus	1.02e-05	0.000175	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.02e-05	0.000175	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.02e-05	0.000174	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—systemic lupus erythematosus	1.01e-05	0.000174	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.01e-05	0.000172	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NOS3—systemic lupus erythematosus	1e-05	0.000172	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JAK1—systemic lupus erythematosus	9.96e-06	0.000171	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.92e-06	0.00017	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	9.84e-06	0.000169	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—systemic lupus erythematosus	9.71e-06	0.000166	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	9.66e-06	0.000166	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	9.63e-06	0.000165	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	9.52e-06	0.000163	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCR5—systemic lupus erythematosus	9.44e-06	0.000162	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.33e-06	0.00016	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2RA—systemic lupus erythematosus	9.3e-06	0.000159	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—systemic lupus erythematosus	9.23e-06	0.000158	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—C3—systemic lupus erythematosus	9.22e-06	0.000158	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	9.19e-06	0.000157	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.15e-06	0.000157	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.13e-06	0.000157	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—systemic lupus erythematosus	8.84e-06	0.000152	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	8.77e-06	0.00015	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EP300—systemic lupus erythematosus	8.71e-06	0.000149	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.7e-06	0.000149	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	8.64e-06	0.000148	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—systemic lupus erythematosus	8.51e-06	0.000146	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	8.49e-06	0.000145	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—systemic lupus erythematosus	8.47e-06	0.000145	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	8.46e-06	0.000145	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.25e-06	0.000141	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	8.19e-06	0.00014	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—F2—systemic lupus erythematosus	8.09e-06	0.000139	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—systemic lupus erythematosus	8.06e-06	0.000138	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	8.03e-06	0.000138	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	7.76e-06	0.000133	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	7.74e-06	0.000133	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EP300—systemic lupus erythematosus	7.64e-06	0.000131	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.6e-06	0.00013	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.57e-06	0.00013	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARG—systemic lupus erythematosus	7.5e-06	0.000129	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.35e-06	0.000126	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.23e-06	0.000124	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	7.22e-06	0.000124	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—systemic lupus erythematosus	7.19e-06	0.000123	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	7.16e-06	0.000123	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	6.81e-06	0.000117	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.78e-06	0.000116	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—systemic lupus erythematosus	6.75e-06	0.000116	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.64e-06	0.000114	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	6.55e-06	0.000112	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EP300—systemic lupus erythematosus	6.45e-06	0.000111	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—NOS3—systemic lupus erythematosus	6.45e-06	0.000111	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—EP300—systemic lupus erythematosus	6.44e-06	0.00011	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	6.43e-06	0.00011	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	6.35e-06	0.000109	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.11e-06	0.000105	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—systemic lupus erythematosus	5.9e-06	0.000101	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	5.71e-06	9.79e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—systemic lupus erythematosus	5.71e-06	9.78e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.61e-06	9.62e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.57e-06	9.55e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	5.53e-06	9.49e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	5.46e-06	9.36e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	5.45e-06	9.34e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	5.42e-06	9.3e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	5.4e-06	9.26e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.17e-06	8.86e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	5.16e-06	8.84e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.14e-06	8.81e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—systemic lupus erythematosus	5e-06	8.57e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	5e-06	8.57e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—systemic lupus erythematosus	4.98e-06	8.53e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—EP300—systemic lupus erythematosus	4.91e-06	8.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	4.89e-06	8.38e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	4.76e-06	8.16e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	4.65e-06	7.97e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.63e-06	7.94e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.45e-06	7.62e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.35e-06	7.46e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.25e-06	7.29e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—systemic lupus erythematosus	4.23e-06	7.25e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	4.16e-06	7.12e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.07e-06	6.97e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—EP300—systemic lupus erythematosus	3.62e-06	6.21e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.41e-06	5.84e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.38e-06	5.8e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	3.2e-06	5.49e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.07e-06	5.25e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.93e-06	5.03e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.68e-06	4.6e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.23e-06	3.82e-05	CbGpPWpGaD
